Edward Havranek
Concepts (460)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 51 | 2018 | 2228 | 2.290 |
Why?
| | Hypertension | 20 | 2022 | 1284 | 2.130 |
Why?
| | Antihypertensive Agents | 9 | 2021 | 488 | 1.840 |
Why?
| | Medication Adherence | 9 | 2022 | 468 | 1.730 |
Why?
| | Text Messaging | 5 | 2020 | 156 | 1.650 |
Why?
| | Healthcare Disparities | 8 | 2023 | 649 | 1.380 |
Why?
| | Socioeconomic Factors | 11 | 2021 | 1281 | 1.160 |
Why?
| | Heart Diseases | 3 | 2019 | 359 | 1.130 |
Why?
| | Social Values | 2 | 2021 | 36 | 1.130 |
Why?
| | Out-of-Hospital Cardiac Arrest | 4 | 2024 | 72 | 1.080 |
Why?
| | Racism | 3 | 2021 | 135 | 1.050 |
Why?
| | Health Status | 12 | 2018 | 781 | 1.020 |
Why?
| | Myocardial Infarction | 17 | 2015 | 1045 | 0.930 |
Why?
| | Blood Pressure | 9 | 2016 | 1772 | 0.890 |
Why?
| | Weight Loss | 5 | 2018 | 775 | 0.870 |
Why?
| | Cardiovascular Diseases | 11 | 2019 | 2108 | 0.830 |
Why?
| | Social Determinants of Health | 2 | 2018 | 250 | 0.820 |
Why?
| | Hospitalization | 24 | 2020 | 2195 | 0.820 |
Why?
| | Prediabetic State | 2 | 2016 | 253 | 0.810 |
Why?
| | Patient Satisfaction | 6 | 2019 | 650 | 0.790 |
Why?
| | Attitude to Health | 2 | 2021 | 439 | 0.760 |
Why?
| | Resuscitation Orders | 2 | 2020 | 44 | 0.760 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2008 | 130 | 0.740 |
Why?
| | Sexual Health | 2 | 2020 | 59 | 0.730 |
Why?
| | Health Services Accessibility | 2 | 2019 | 976 | 0.720 |
Why?
| | Physician-Patient Relations | 5 | 2013 | 544 | 0.710 |
Why?
| | Aged | 79 | 2021 | 23729 | 0.700 |
Why?
| | Sexually Transmitted Diseases | 2 | 2020 | 158 | 0.700 |
Why?
| | Humans | 143 | 2024 | 136783 | 0.690 |
Why?
| | Middle Aged | 60 | 2022 | 33200 | 0.650 |
Why?
| | Health Status Disparities | 3 | 2021 | 284 | 0.650 |
Why?
| | Male | 100 | 2024 | 67361 | 0.630 |
Why?
| | Female | 103 | 2024 | 72840 | 0.630 |
Why?
| | Cardiac Output, Low | 5 | 2006 | 66 | 0.630 |
Why?
| | Depression | 8 | 2018 | 1402 | 0.630 |
Why?
| | Residence Characteristics | 3 | 2021 | 354 | 0.600 |
Why?
| | Primary Health Care | 4 | 2019 | 1714 | 0.600 |
Why?
| | Diabetes Mellitus | 9 | 2018 | 1033 | 0.570 |
Why?
| | Atherosclerosis | 2 | 2019 | 415 | 0.570 |
Why?
| | Choice Behavior | 1 | 2019 | 171 | 0.560 |
Why?
| | Colorado | 22 | 2021 | 4491 | 0.560 |
Why?
| | United States | 44 | 2023 | 14660 | 0.540 |
Why?
| | Minority Groups | 3 | 2023 | 267 | 0.530 |
Why?
| | Heart Arrest | 2 | 2020 | 339 | 0.510 |
Why?
| | Communication | 4 | 2023 | 869 | 0.500 |
Why?
| | American Heart Association | 3 | 2018 | 306 | 0.480 |
Why?
| | Safety-net Providers | 2 | 2018 | 117 | 0.470 |
Why?
| | Cardiopulmonary Resuscitation | 4 | 2024 | 250 | 0.470 |
Why?
| | Emergency Medical Services | 4 | 2023 | 548 | 0.450 |
Why?
| | Emergency Service, Hospital | 5 | 2021 | 2050 | 0.450 |
Why?
| | Health Services Research | 2 | 2015 | 400 | 0.450 |
Why?
| | Quality of Health Care | 8 | 2007 | 627 | 0.440 |
Why?
| | Delivery of Health Care | 7 | 2023 | 939 | 0.420 |
Why?
| | Blood Pressure Determination | 1 | 2014 | 156 | 0.400 |
Why?
| | Risk Factors | 26 | 2019 | 10331 | 0.400 |
Why?
| | Ventricular Dysfunction, Left | 7 | 2008 | 389 | 0.390 |
Why?
| | Aged, 80 and over | 29 | 2021 | 7569 | 0.390 |
Why?
| | Medically Uninsured | 1 | 2013 | 129 | 0.380 |
Why?
| | Patient Acceptance of Health Care | 1 | 2018 | 806 | 0.380 |
Why?
| | Guideline Adherence | 6 | 2021 | 543 | 0.380 |
Why?
| | Surveys and Questionnaires | 11 | 2024 | 5749 | 0.370 |
Why?
| | Patient-Centered Care | 2 | 2016 | 520 | 0.360 |
Why?
| | Decision Making | 2 | 2016 | 896 | 0.360 |
Why?
| | Adult | 31 | 2024 | 37616 | 0.360 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 2 | 2011 | 85 | 0.350 |
Why?
| | Physicians, Primary Care | 2 | 2018 | 232 | 0.350 |
Why?
| | Kidney Diseases | 3 | 2011 | 406 | 0.350 |
Why?
| | Decision Support Techniques | 1 | 2015 | 418 | 0.350 |
Why?
| | Survival Analysis | 7 | 2010 | 1319 | 0.350 |
Why?
| | Carotid Artery Diseases | 1 | 2011 | 66 | 0.350 |
Why?
| | Electrocardiography | 4 | 2009 | 628 | 0.340 |
Why?
| | Insurance, Health | 1 | 2013 | 278 | 0.340 |
Why?
| | Follow-Up Studies | 17 | 2022 | 5115 | 0.340 |
Why?
| | Cohort Studies | 26 | 2020 | 5718 | 0.340 |
Why?
| | Risk Assessment | 10 | 2019 | 3429 | 0.330 |
Why?
| | Practice Patterns, Physicians' | 3 | 2018 | 1294 | 0.330 |
Why?
| | Coronary Artery Disease | 3 | 2013 | 702 | 0.330 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 9 | 2008 | 201 | 0.320 |
Why?
| | Survival Rate | 13 | 2020 | 1969 | 0.290 |
Why?
| | Attitude to Death | 1 | 2008 | 68 | 0.290 |
Why?
| | Quality of Life | 12 | 2019 | 2868 | 0.280 |
Why?
| | Renin-Angiotensin System | 1 | 2008 | 84 | 0.280 |
Why?
| | Proportional Hazards Models | 11 | 2015 | 1260 | 0.280 |
Why?
| | Heart Rate | 2 | 2011 | 823 | 0.270 |
Why?
| | Exercise | 2 | 2018 | 2038 | 0.270 |
Why?
| | Patient Education as Topic | 4 | 2018 | 760 | 0.270 |
Why?
| | Medicare | 14 | 2017 | 747 | 0.270 |
Why?
| | Atrial Fibrillation | 2 | 2009 | 390 | 0.260 |
Why?
| | Stroke | 3 | 2021 | 1129 | 0.260 |
Why?
| | Diabetic Angiopathies | 4 | 2009 | 258 | 0.260 |
Why?
| | Models, Statistical | 2 | 2013 | 658 | 0.250 |
Why?
| | Sex Factors | 10 | 2020 | 2068 | 0.240 |
Why?
| | Retrospective Studies | 30 | 2020 | 15564 | 0.240 |
Why?
| | Kidney | 3 | 2011 | 1463 | 0.240 |
Why?
| | Value of Life | 1 | 2005 | 17 | 0.240 |
Why?
| | Prevalence | 7 | 2018 | 2712 | 0.230 |
Why?
| | Multivariate Analysis | 10 | 2017 | 1513 | 0.230 |
Why?
| | Cross-Sectional Studies | 14 | 2017 | 5417 | 0.230 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2017 | 99 | 0.230 |
Why?
| | Monitoring, Ambulatory | 1 | 2005 | 87 | 0.220 |
Why?
| | Ambulances | 2 | 2023 | 51 | 0.220 |
Why?
| | Touch Perception | 1 | 2024 | 17 | 0.220 |
Why?
| | Patient Compliance | 4 | 2018 | 576 | 0.220 |
Why?
| | Palliative Care | 4 | 2016 | 743 | 0.220 |
Why?
| | Peer Review, Research | 1 | 2004 | 43 | 0.210 |
Why?
| | Epidemiologic Studies | 1 | 2004 | 72 | 0.210 |
Why?
| | Prognosis | 9 | 2018 | 4018 | 0.210 |
Why?
| | Nisoldipine | 1 | 2003 | 7 | 0.210 |
Why?
| | Single-Blind Method | 2 | 2021 | 286 | 0.210 |
Why?
| | Enalapril | 1 | 2003 | 16 | 0.210 |
Why?
| | Young Adult | 9 | 2021 | 13126 | 0.210 |
Why?
| | Shock, Traumatic | 1 | 2023 | 14 | 0.210 |
Why?
| | Smoking Cessation | 1 | 2007 | 446 | 0.200 |
Why?
| | Attitude of Health Personnel | 2 | 2012 | 1157 | 0.200 |
Why?
| | Pneumonia | 2 | 2019 | 638 | 0.200 |
Why?
| | Treatment Outcome | 15 | 2023 | 10764 | 0.190 |
Why?
| | Sexual Behavior | 3 | 2020 | 485 | 0.190 |
Why?
| | Social Class | 2 | 2019 | 277 | 0.190 |
Why?
| | Sepsis | 2 | 2019 | 611 | 0.190 |
Why?
| | Mexican Americans | 2 | 2015 | 117 | 0.190 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2005 | 256 | 0.190 |
Why?
| | Intention to Treat Analysis | 1 | 2021 | 73 | 0.190 |
Why?
| | Hypoglycemic Agents | 5 | 2012 | 1281 | 0.180 |
Why?
| | Communication Barriers | 1 | 2023 | 104 | 0.180 |
Why?
| | Perception | 1 | 2004 | 356 | 0.180 |
Why?
| | Prospective Studies | 12 | 2019 | 7583 | 0.180 |
Why?
| | Critical Illness | 2 | 2023 | 807 | 0.180 |
Why?
| | Acculturation | 2 | 2012 | 53 | 0.180 |
Why?
| | Cardiologists | 2 | 2018 | 45 | 0.170 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2017 | 2512 | 0.170 |
Why?
| | Glomerular Filtration Rate | 5 | 2011 | 744 | 0.170 |
Why?
| | Telemedicine | 2 | 2011 | 847 | 0.170 |
Why?
| | Drug Prescriptions | 6 | 2009 | 247 | 0.170 |
Why?
| | Stroke Volume | 7 | 2008 | 619 | 0.170 |
Why?
| | Professional-Patient Relations | 1 | 2021 | 143 | 0.170 |
Why?
| | Electronic Health Records | 2 | 2018 | 1036 | 0.170 |
Why?
| | Writing | 1 | 2021 | 94 | 0.170 |
Why?
| | Brain Ischemia | 2 | 2021 | 341 | 0.170 |
Why?
| | Incidence | 6 | 2021 | 2788 | 0.160 |
Why?
| | Age Factors | 11 | 2018 | 3290 | 0.160 |
Why?
| | Chi-Square Distribution | 5 | 2015 | 532 | 0.160 |
Why?
| | Chronic Disease | 6 | 2018 | 1784 | 0.160 |
Why?
| | Adolescent | 10 | 2020 | 21463 | 0.160 |
Why?
| | Quality Assurance, Health Care | 6 | 2007 | 322 | 0.150 |
Why?
| | Cardiology | 3 | 2007 | 278 | 0.150 |
Why?
| | Health Care Surveys | 4 | 2019 | 563 | 0.150 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2024 | 1323 | 0.150 |
Why?
| | Shock | 1 | 2020 | 95 | 0.150 |
Why?
| | Time Factors | 10 | 2015 | 6792 | 0.150 |
Why?
| | Fluid Therapy | 1 | 2020 | 147 | 0.150 |
Why?
| | Public Opinion | 1 | 2019 | 65 | 0.150 |
Why?
| | Income | 1 | 2019 | 200 | 0.150 |
Why?
| | Formative Feedback | 1 | 2018 | 28 | 0.150 |
Why?
| | Medical Audit | 1 | 2018 | 76 | 0.150 |
Why?
| | Emergency Treatment | 1 | 2019 | 117 | 0.150 |
Why?
| | Patient Selection | 5 | 2009 | 689 | 0.140 |
Why?
| | Health Literacy | 2 | 2018 | 169 | 0.140 |
Why?
| | Withholding Treatment | 2 | 2016 | 76 | 0.140 |
Why?
| | Multilevel Analysis | 1 | 2017 | 30 | 0.140 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2831 | 0.140 |
Why?
| | Censuses | 1 | 2017 | 31 | 0.140 |
Why?
| | Patient Readmission | 5 | 2012 | 695 | 0.140 |
Why?
| | Patient Care Team | 2 | 2018 | 627 | 0.140 |
Why?
| | Angina Pectoris | 2 | 2008 | 66 | 0.140 |
Why?
| | California | 1 | 2019 | 424 | 0.140 |
Why?
| | Contraception | 1 | 2019 | 162 | 0.140 |
Why?
| | Odds Ratio | 6 | 2018 | 1063 | 0.140 |
Why?
| | Patient Navigation | 1 | 2019 | 79 | 0.140 |
Why?
| | International Cooperation | 1 | 2018 | 198 | 0.140 |
Why?
| | Goals | 1 | 2018 | 168 | 0.140 |
Why?
| | ST Elevation Myocardial Infarction | 1 | 2017 | 54 | 0.130 |
Why?
| | Hyperglycemia | 3 | 2010 | 346 | 0.130 |
Why?
| | Comorbidity | 9 | 2012 | 1611 | 0.130 |
Why?
| | Statistics as Topic | 3 | 2008 | 311 | 0.130 |
Why?
| | Peer Group | 1 | 2019 | 244 | 0.130 |
Why?
| | Interviews as Topic | 3 | 2015 | 766 | 0.130 |
Why?
| | Logistic Models | 9 | 2017 | 2060 | 0.130 |
Why?
| | Qualitative Research | 3 | 2019 | 1359 | 0.130 |
Why?
| | Program Development | 1 | 2018 | 365 | 0.130 |
Why?
| | Organizational Case Studies | 1 | 2015 | 78 | 0.120 |
Why?
| | Cell Phone | 1 | 2016 | 75 | 0.120 |
Why?
| | Diuretics | 3 | 2006 | 74 | 0.120 |
Why?
| | Self-Management | 1 | 2018 | 166 | 0.120 |
Why?
| | Hospital Mortality | 5 | 2019 | 900 | 0.120 |
Why?
| | Weight Reduction Programs | 1 | 2017 | 116 | 0.120 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2016 | 91 | 0.120 |
Why?
| | Urban Population | 1 | 2018 | 472 | 0.120 |
Why?
| | Registries | 6 | 2020 | 2015 | 0.120 |
Why?
| | Xanthines | 2 | 2007 | 19 | 0.120 |
Why?
| | Predictive Value of Tests | 4 | 2010 | 2030 | 0.120 |
Why?
| | Diffusion of Innovation | 1 | 2015 | 98 | 0.120 |
Why?
| | Leadership | 2 | 2018 | 380 | 0.120 |
Why?
| | Thiazolidinediones | 3 | 2005 | 137 | 0.120 |
Why?
| | Renal Dialysis | 1 | 2019 | 434 | 0.120 |
Why?
| | Organizational Innovation | 1 | 2015 | 138 | 0.110 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 318 | 0.110 |
Why?
| | Community Health Services | 2 | 2008 | 228 | 0.110 |
Why?
| | Education, Medical | 1 | 2018 | 260 | 0.110 |
Why?
| | Hypercholesterolemia | 1 | 2015 | 105 | 0.110 |
Why?
| | Exercise Test | 1 | 2017 | 625 | 0.110 |
Why?
| | Organizational Culture | 1 | 2015 | 144 | 0.110 |
Why?
| | Lipoproteins | 1 | 2015 | 167 | 0.110 |
Why?
| | Blood Vessels | 1 | 2016 | 187 | 0.110 |
Why?
| | Cultural Competency | 2 | 2013 | 87 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2015 | 139 | 0.110 |
Why?
| | Acute Coronary Syndrome | 1 | 2017 | 275 | 0.110 |
Why?
| | ROC Curve | 2 | 2020 | 545 | 0.110 |
Why?
| | Ventricular Function, Left | 4 | 2009 | 540 | 0.110 |
Why?
| | Adiponectin | 1 | 2015 | 243 | 0.110 |
Why?
| | Practice Guidelines as Topic | 4 | 2017 | 1568 | 0.110 |
Why?
| | Cholesterol | 1 | 2015 | 410 | 0.100 |
Why?
| | Pilot Projects | 3 | 2015 | 1697 | 0.100 |
Why?
| | Creatinine | 5 | 2006 | 498 | 0.100 |
Why?
| | Aspirin | 3 | 2005 | 384 | 0.100 |
Why?
| | Triglycerides | 1 | 2015 | 524 | 0.100 |
Why?
| | Kidney Failure, Chronic | 1 | 2019 | 565 | 0.100 |
Why?
| | Disease Management | 3 | 2008 | 623 | 0.100 |
Why?
| | Diabetes Complications | 3 | 2009 | 226 | 0.100 |
Why?
| | Metformin | 3 | 2005 | 329 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 2 | 2015 | 891 | 0.090 |
Why?
| | Inpatients | 5 | 2009 | 499 | 0.090 |
Why?
| | Hyperlipidemias | 1 | 2012 | 120 | 0.090 |
Why?
| | Trust | 1 | 2012 | 120 | 0.090 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2005 | 1455 | 0.090 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2006 | 442 | 0.090 |
Why?
| | Hospitals, Military | 1 | 2011 | 25 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1942 | 0.090 |
Why?
| | Medical Laboratory Science | 1 | 2010 | 9 | 0.090 |
Why?
| | Adiposity | 1 | 2015 | 518 | 0.090 |
Why?
| | Health Promotion | 1 | 2017 | 736 | 0.090 |
Why?
| | Adrenergic beta-Antagonists | 3 | 2008 | 323 | 0.090 |
Why?
| | Anticholesteremic Agents | 1 | 2012 | 153 | 0.080 |
Why?
| | Vascular Stiffness | 1 | 2015 | 493 | 0.080 |
Why?
| | Biomedical Research | 2 | 2007 | 689 | 0.080 |
Why?
| | Telephone | 1 | 2011 | 170 | 0.080 |
Why?
| | Affect | 1 | 2012 | 293 | 0.080 |
Why?
| | Diet | 2 | 2015 | 1273 | 0.080 |
Why?
| | Pregnancy | 2 | 2020 | 6731 | 0.080 |
Why?
| | Health Status Indicators | 3 | 2008 | 171 | 0.080 |
Why?
| | Double-Blind Method | 4 | 2015 | 1981 | 0.080 |
Why?
| | Nutrition Surveys | 2 | 2008 | 267 | 0.080 |
Why?
| | Body Mass Index | 2 | 2016 | 2364 | 0.080 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 2009 | 140 | 0.080 |
Why?
| | Captopril | 1 | 2008 | 11 | 0.070 |
Why?
| | Pharmacists | 1 | 2011 | 260 | 0.070 |
Why?
| | Valsartan | 1 | 2008 | 29 | 0.070 |
Why?
| | Obesity | 2 | 2015 | 2975 | 0.070 |
Why?
| | Tetrazoles | 1 | 2008 | 40 | 0.070 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 38 | 0.070 |
Why?
| | Spouse Abuse | 1 | 2008 | 41 | 0.070 |
Why?
| | Spironolactone | 2 | 2005 | 35 | 0.070 |
Why?
| | Valine | 1 | 2008 | 82 | 0.070 |
Why?
| | Carbazoles | 1 | 2008 | 83 | 0.070 |
Why?
| | Adenosine A1 Receptor Antagonists | 1 | 2007 | 2 | 0.070 |
Why?
| | Spirituality | 1 | 2009 | 83 | 0.070 |
Why?
| | Health Surveys | 1 | 2010 | 517 | 0.070 |
Why?
| | Linear Models | 4 | 2015 | 845 | 0.070 |
Why?
| | Propanolamines | 1 | 2008 | 96 | 0.070 |
Why?
| | Medical Records Systems, Computerized | 1 | 2008 | 92 | 0.070 |
Why?
| | Patients | 1 | 2009 | 173 | 0.070 |
Why?
| | Longitudinal Studies | 3 | 2011 | 2847 | 0.070 |
Why?
| | Medically Underserved Area | 1 | 2008 | 86 | 0.070 |
Why?
| | Insulin Resistance | 1 | 2015 | 1201 | 0.070 |
Why?
| | Social Workers | 2 | 2018 | 41 | 0.070 |
Why?
| | Vascular Diseases | 1 | 2009 | 244 | 0.070 |
Why?
| | United States Department of Veterans Affairs | 1 | 2011 | 670 | 0.070 |
Why?
| | Self Care | 1 | 2009 | 375 | 0.060 |
Why?
| | Blood Urea Nitrogen | 1 | 2006 | 53 | 0.060 |
Why?
| | Defibrillators, Implantable | 1 | 2010 | 315 | 0.060 |
Why?
| | Diet, Sodium-Restricted | 1 | 2006 | 36 | 0.060 |
Why?
| | National Health Programs | 1 | 2005 | 21 | 0.060 |
Why?
| | Internal Medicine | 1 | 2008 | 251 | 0.060 |
Why?
| | Patient Admission | 4 | 2009 | 191 | 0.060 |
Why?
| | Coronary Artery Bypass | 2 | 2006 | 238 | 0.060 |
Why?
| | Body Temperature | 1 | 2006 | 220 | 0.060 |
Why?
| | Dyspnea | 2 | 2018 | 251 | 0.060 |
Why?
| | Edema | 1 | 2006 | 129 | 0.060 |
Why?
| | Fatigue | 2 | 2018 | 327 | 0.060 |
Why?
| | Cost of Illness | 2 | 2004 | 300 | 0.060 |
Why?
| | Biomarkers | 6 | 2015 | 4158 | 0.060 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2005 | 101 | 0.060 |
Why?
| | Interinstitutional Relations | 1 | 2005 | 54 | 0.060 |
Why?
| | Health Education | 1 | 2008 | 337 | 0.060 |
Why?
| | Patient Discharge | 4 | 2006 | 896 | 0.060 |
Why?
| | Hospital Costs | 1 | 2005 | 119 | 0.060 |
Why?
| | Terminally Ill | 1 | 2005 | 37 | 0.060 |
Why?
| | Self Report | 2 | 2022 | 825 | 0.060 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2005 | 87 | 0.060 |
Why?
| | Drug Costs | 1 | 2005 | 106 | 0.060 |
Why?
| | Nurses | 2 | 2018 | 173 | 0.060 |
Why?
| | Asthma | 1 | 2018 | 2290 | 0.060 |
Why?
| | Specialization | 1 | 2005 | 143 | 0.060 |
Why?
| | Coronary Care Units | 1 | 2004 | 19 | 0.060 |
Why?
| | Depressive Disorder | 1 | 2007 | 380 | 0.050 |
Why?
| | Anemia | 1 | 2005 | 170 | 0.050 |
Why?
| | United Kingdom | 1 | 2005 | 315 | 0.050 |
Why?
| | Counseling | 1 | 2007 | 391 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2005 | 307 | 0.050 |
Why?
| | Nurse Administrators | 1 | 2004 | 44 | 0.050 |
Why?
| | Nurse Practitioners | 1 | 2006 | 135 | 0.050 |
Why?
| | Cultural Characteristics | 1 | 2004 | 66 | 0.050 |
Why?
| | Medicine | 1 | 2005 | 119 | 0.050 |
Why?
| | Educational Status | 1 | 2006 | 482 | 0.050 |
Why?
| | North America | 1 | 2004 | 313 | 0.050 |
Why?
| | Internet | 1 | 2008 | 648 | 0.050 |
Why?
| | Patient Reported Outcome Measures | 2 | 2018 | 400 | 0.050 |
Why?
| | Ibuprofen | 1 | 2003 | 84 | 0.050 |
Why?
| | Vulnerable Populations | 1 | 2004 | 163 | 0.050 |
Why?
| | Alcohol Drinking | 2 | 2009 | 818 | 0.050 |
Why?
| | Albuminuria | 1 | 2004 | 185 | 0.050 |
Why?
| | Thiazoles | 1 | 2003 | 123 | 0.050 |
Why?
| | Needs Assessment | 1 | 2005 | 369 | 0.050 |
Why?
| | Health Behavior | 2 | 2011 | 756 | 0.050 |
Why?
| | South Africa | 1 | 2023 | 219 | 0.050 |
Why?
| | Continuity of Patient Care | 1 | 2005 | 278 | 0.050 |
Why?
| | Purinergic P1 Receptor Antagonists | 1 | 2002 | 8 | 0.050 |
Why?
| | Diuresis | 1 | 2002 | 10 | 0.050 |
Why?
| | Risk Reduction Behavior | 1 | 2004 | 218 | 0.050 |
Why?
| | Hypertension, Malignant | 1 | 2002 | 2 | 0.050 |
Why?
| | Calcium Channel Blockers | 1 | 2003 | 167 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2004 | 400 | 0.050 |
Why?
| | Weight Gain | 1 | 2006 | 518 | 0.050 |
Why?
| | Cardiac Tamponade | 1 | 2002 | 15 | 0.050 |
Why?
| | Furosemide | 1 | 2002 | 37 | 0.050 |
Why?
| | Total Quality Management | 1 | 2002 | 60 | 0.050 |
Why?
| | Cooperative Behavior | 1 | 2005 | 443 | 0.050 |
Why?
| | Pain Measurement | 1 | 2004 | 522 | 0.050 |
Why?
| | Hospice Care | 1 | 2005 | 201 | 0.050 |
Why?
| | Ambulatory Care | 2 | 2006 | 538 | 0.050 |
Why?
| | Lupus Nephritis | 1 | 2002 | 63 | 0.050 |
Why?
| | Health Care Costs | 1 | 2004 | 385 | 0.050 |
Why?
| | Health Maintenance Organizations | 2 | 2012 | 96 | 0.040 |
Why?
| | Forecasting | 1 | 2002 | 384 | 0.040 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 350 | 0.040 |
Why?
| | Mortality | 2 | 2018 | 357 | 0.040 |
Why?
| | Algorithms | 1 | 2008 | 1686 | 0.040 |
Why?
| | Contraindications | 3 | 2005 | 90 | 0.040 |
Why?
| | Emergencies | 1 | 2021 | 164 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2012 | 328 | 0.040 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2003 | 460 | 0.040 |
Why?
| | Family Practice | 1 | 2004 | 455 | 0.040 |
Why?
| | Risk Adjustment | 1 | 2020 | 78 | 0.040 |
Why?
| | Coronary Disease | 1 | 2002 | 385 | 0.040 |
Why?
| | Veterans | 1 | 2011 | 1457 | 0.040 |
Why?
| | Area Under Curve | 1 | 2020 | 313 | 0.040 |
Why?
| | Blood Glucose | 2 | 2009 | 2180 | 0.040 |
Why?
| | Sexuality | 1 | 2019 | 32 | 0.040 |
Why?
| | Electric Countershock | 1 | 2019 | 107 | 0.040 |
Why?
| | Geographic Mapping | 1 | 2018 | 23 | 0.040 |
Why?
| | Research | 2 | 2018 | 445 | 0.040 |
Why?
| | Length of Stay | 2 | 2017 | 1208 | 0.040 |
Why?
| | Program Evaluation | 2 | 2018 | 886 | 0.040 |
Why?
| | Zimbabwe | 1 | 2018 | 55 | 0.040 |
Why?
| | Hospitals | 1 | 2003 | 677 | 0.040 |
Why?
| | Palliative Medicine | 1 | 2018 | 15 | 0.040 |
Why?
| | Patient Health Questionnaire | 1 | 2018 | 37 | 0.040 |
Why?
| | Alcoholism | 1 | 2004 | 804 | 0.040 |
Why?
| | Combined Modality Therapy | 2 | 2011 | 1235 | 0.030 |
Why?
| | Capacity Building | 1 | 2018 | 62 | 0.030 |
Why?
| | Resuscitation | 1 | 2020 | 250 | 0.030 |
Why?
| | Cholesterol, LDL | 2 | 2012 | 366 | 0.030 |
Why?
| | Anxiety | 2 | 2018 | 1032 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2020 | 1318 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2018 | 203 | 0.030 |
Why?
| | Secondary Prevention | 1 | 2018 | 233 | 0.030 |
Why?
| | Emotional Adjustment | 1 | 2016 | 17 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 376 | 0.030 |
Why?
| | Peer Review | 2 | 2007 | 50 | 0.030 |
Why?
| | Primary Prevention | 1 | 2018 | 196 | 0.030 |
Why?
| | Sex Offenses | 1 | 2019 | 194 | 0.030 |
Why?
| | Emergency Medicine | 1 | 2018 | 224 | 0.030 |
Why?
| | Diet Surveys | 1 | 2015 | 95 | 0.030 |
Why?
| | Protective Factors | 1 | 2015 | 93 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2017 | 228 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2020 | 642 | 0.030 |
Why?
| | Population Surveillance | 1 | 2018 | 470 | 0.030 |
Why?
| | Medical Records | 2 | 2006 | 172 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2015 | 197 | 0.030 |
Why?
| | Pulse Wave Analysis | 1 | 2016 | 269 | 0.030 |
Why?
| | Canada | 2 | 2006 | 420 | 0.030 |
Why?
| | Motivation | 1 | 2020 | 563 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 947 | 0.030 |
Why?
| | Regression Analysis | 2 | 2009 | 1024 | 0.030 |
Why?
| | Language | 1 | 2017 | 296 | 0.030 |
Why?
| | Mineralocorticoid Receptor Antagonists | 2 | 2005 | 54 | 0.030 |
Why?
| | Administration, Oral | 2 | 2007 | 808 | 0.030 |
Why?
| | Neoplasms | 1 | 2009 | 2644 | 0.030 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2002 | 1042 | 0.030 |
Why?
| | Consensus | 2 | 2007 | 679 | 0.030 |
Why?
| | Pain Management | 1 | 2016 | 347 | 0.030 |
Why?
| | Stereotyped Behavior | 1 | 2012 | 19 | 0.030 |
Why?
| | Up-Regulation | 1 | 2015 | 843 | 0.020 |
Why?
| | Aging | 1 | 2003 | 1861 | 0.020 |
Why?
| | Pain | 1 | 2018 | 755 | 0.020 |
Why?
| | Quality Indicators, Health Care | 2 | 2006 | 308 | 0.020 |
Why?
| | Cardiac Resynchronization Therapy | 1 | 2012 | 46 | 0.020 |
Why?
| | Disease Progression | 2 | 2011 | 2750 | 0.020 |
Why?
| | Culture | 1 | 2012 | 127 | 0.020 |
Why?
| | Speech Recognition Software | 1 | 2010 | 11 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2007 | 2045 | 0.020 |
Why?
| | User-Computer Interface | 1 | 2010 | 157 | 0.020 |
Why?
| | Cause of Death | 1 | 2012 | 429 | 0.020 |
Why?
| | Urban Health Services | 1 | 2009 | 63 | 0.020 |
Why?
| | Medication Therapy Management | 1 | 2010 | 75 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1799 | 0.020 |
Why?
| | Hospitals, University | 1 | 2008 | 180 | 0.020 |
Why?
| | Natriuresis | 1 | 2007 | 15 | 0.020 |
Why?
| | Kidney Function Tests | 1 | 2007 | 159 | 0.020 |
Why?
| | Patient Participation | 1 | 2010 | 416 | 0.020 |
Why?
| | Risk | 1 | 2009 | 904 | 0.020 |
Why?
| | Ontario | 1 | 2006 | 156 | 0.020 |
Why?
| | Pravastatin | 1 | 2006 | 41 | 0.020 |
Why?
| | Lovastatin | 1 | 2006 | 37 | 0.020 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2006 | 54 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2009 | 283 | 0.020 |
Why?
| | Heptanoic Acids | 1 | 2006 | 66 | 0.020 |
Why?
| | Databases as Topic | 1 | 2005 | 66 | 0.020 |
Why?
| | Hematocrit | 1 | 2005 | 95 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 783 | 0.010 |
Why?
| | Cognition Disorders | 1 | 2009 | 515 | 0.010 |
Why?
| | Hospitals, Teaching | 1 | 2005 | 116 | 0.010 |
Why?
| | Hospitals, Urban | 1 | 2005 | 134 | 0.010 |
Why?
| | Midwestern United States | 1 | 2004 | 45 | 0.010 |
Why?
| | Northwestern United States | 1 | 2004 | 55 | 0.010 |
Why?
| | Family | 1 | 2009 | 666 | 0.010 |
Why?
| | Pyrroles | 1 | 2006 | 211 | 0.010 |
Why?
| | Potassium | 1 | 2005 | 147 | 0.010 |
Why?
| | Hospitals, Municipal | 1 | 2004 | 1 | 0.010 |
Why?
| | Age Distribution | 1 | 2005 | 391 | 0.010 |
Why?
| | Myocardial Revascularization | 1 | 2004 | 73 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 2006 | 687 | 0.010 |
Why?
| | Cognition | 1 | 2012 | 1166 | 0.010 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2004 | 114 | 0.010 |
Why?
| | Drug Utilization | 1 | 2004 | 170 | 0.010 |
Why?
| | Drug Utilization Review | 1 | 2003 | 56 | 0.010 |
Why?
| | Smoking | 1 | 2011 | 1633 | 0.010 |
Why?
| | Fee-for-Service Plans | 1 | 2003 | 85 | 0.010 |
Why?
| | Cardiotonic Agents | 1 | 2003 | 125 | 0.010 |
Why?
| | Indoles | 1 | 2006 | 410 | 0.010 |
Why?
| | Arrhythmias, Cardiac | 1 | 2005 | 331 | 0.010 |
Why?
| | Drug Interactions | 1 | 2003 | 405 | 0.010 |
Why?
| | Pyridines | 1 | 2006 | 505 | 0.010 |
Why?
| | Overweight | 1 | 2006 | 557 | 0.010 |
Why?
| | Electrolytes | 1 | 2002 | 58 | 0.010 |
Why?
| | Urinalysis | 1 | 2002 | 77 | 0.010 |
Why?
| | Cardiac Catheterization | 1 | 2004 | 527 | 0.010 |
Why?
| | Sodium | 1 | 2002 | 214 | 0.010 |
Why?
| | Drug Combinations | 1 | 2002 | 344 | 0.010 |
Why?
| | Morbidity | 1 | 2002 | 322 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2003 | 1059 | 0.010 |
Why?
| | Diabetic Nephropathies | 1 | 2004 | 293 | 0.010 |
Why?
| | Heart Ventricles | 1 | 2005 | 792 | 0.010 |
Why?
| | Referral and Consultation | 1 | 2005 | 777 | 0.010 |
Why?
| | Cross-Over Studies | 1 | 2002 | 560 | 0.010 |
Why?
| | Recovery of Function | 1 | 2003 | 655 | 0.010 |
Why?
| | Mental Disorders | 1 | 2008 | 1075 | 0.010 |
Why?
| | Substance-Related Disorders | 1 | 2008 | 1072 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2005 | 3537 | 0.010 |
Why?
| | Hemodynamics | 1 | 2002 | 1110 | 0.010 |
Why?
| | Internship and Residency | 1 | 2004 | 1131 | 0.010 |
Why?
|
|
Havranek's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|